{"id":"https://openalex.org/W7206166182","doi":"https://doi.org/10.17605/osf.io/8tgx4","title":"Personalized mRNA Neoantigen Vaccines in Cancer: From Tumor Sequencing to Phase 3 Clinical Evidence","display_name":"Personalized mRNA Neoantigen Vaccines in Cancer: From Tumor Sequencing to Phase 3 Clinical Evidence","publication_year":2026,"publication_date":"2026-09-02","ids":{"openalex":"https://openalex.org/W7206166182","doi":"https://doi.org/10.17605/osf.io/8tgx4"},"language":"en","primary_location":{"id":"doi:10.17605/osf.io/8tgx4","doi":"https://doi.org/10.17605/osf.io/8tgx4","is_oa":true,"landing_page_url":"https://doi.org/10.17605/osf.io/8tgx4","pdf_url":null,"source":{"id":"https://openalex.org/S7407050956","display_name":"Open Science Framework","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2799848540","host_organization_name":"Center for Open Science","host_organization_lineage":["https://openalex.org/I2799848540"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"StudyRegistration"},"volume":null,"type":"study-registration","is_traditional":false,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.17605/osf.io/8tgx4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5149310897","display_name":"Juhayra Farhin","orcid":"https://orcid.org/0009-0009-7162-8181","observed_orcids":["https://orcid.org/0009-0009-7162-8181"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juhayra Farhin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-7162-8181","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134393990","display_name":"Ghezal Dabiry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ghezal Dabiry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144241165","display_name":"Abiya Ahad","orcid":"https://orcid.org/0009-0008-5767-0722","observed_orcids":["https://orcid.org/0009-0008-5767-0722"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abiya Ahad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116300988","display_name":"Valbona Imeri","orcid":"https://orcid.org/0009-0000-8768-6866","observed_orcids":["https://orcid.org/0009-0000-8768-6866"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valbona Imeri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149174673","display_name":"Mukhammedaziz Nuretov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mukhammedaziz Nuretov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149273274","display_name":"Alekhya","orcid":"https://orcid.org/0009-0009-9620-0632","observed_orcids":["https://orcid.org/0009-0009-9620-0632"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alekhya","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-9620-0632","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149194119","display_name":"Muhammed Annaan Y\u0131lmazo\u011flu","orcid":"https://orcid.org/0009-0007-7325-0245","observed_orcids":["https://orcid.org/0009-0007-7325-0245"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muhammed Annaan Y\u0131lmazo\u011flu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-7325-0245","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5149249496","display_name":"Mayar Eyad","orcid":"https://orcid.org/0009-0004-0186-5513","observed_orcids":["https://orcid.org/0009-0004-0186-5513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mayar Eyad","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-0186-5513","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6621000170707703,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6621000170707703,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.33570000529289246,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoantigen-vaccines","display_name":"neoantigen vaccines","score":0.8320000171661377},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/tumor-sequencing","display_name":"tumor sequencing","score":0.8510000109672546},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.8980000019073486},{"id":"https://openalex.org/keywords/mrna-vaccine-design","display_name":"mRNA vaccine design","score":0.675000011920929},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7440000176429749},{"id":"https://openalex.org/keywords/vaccine-trials","display_name":"vaccine clinical trials","score":0.36500000953674316},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.39800000190734863},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.45500001311302185},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5070000290870667},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6650000214576721},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9240000247955322}],"concepts":[{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.597000002861023},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5877000093460083},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5591999888420105},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5519000291824341},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5311999917030334},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.47780001163482666},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.45399999618530273},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4212000072002411},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.40529999136924744},{"id":"https://openalex.org/C149364088","wikidata":"https://www.wikidata.org/wiki/Q185917","display_name":"Translation (biology)","level":4,"score":0.4034999907016754},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3869999945163727},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37470000982284546},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.37369999289512634},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.3684000074863434},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3553999960422516},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3529999852180481},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.35179999470710754},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32690000534057617},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.3174000084400177},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.31279999017715454},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.30300000309944153},{"id":"https://openalex.org/C51679486","wikidata":"https://www.wikidata.org/wiki/Q380546","display_name":"DNA sequencing","level":3,"score":0.2939999997615814},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.29010000824928284},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.28029999136924744},{"id":"https://openalex.org/C132917006","wikidata":"https://www.wikidata.org/wiki/Q5250436","display_name":"Deep sequencing","level":4,"score":0.2784000039100647},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.2750999927520752},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.271699994802475},{"id":"https://openalex.org/C189206191","wikidata":"https://www.wikidata.org/wiki/Q222046","display_name":"Genomics","level":4,"score":0.26190000772476196},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.2549000084400177},{"id":"https://openalex.org/C3019217517","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor associated antigen","level":4,"score":0.2547000050544739}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.17605/osf.io/8tgx4","doi":"https://doi.org/10.17605/osf.io/8tgx4","is_oa":true,"landing_page_url":"https://doi.org/10.17605/osf.io/8tgx4","pdf_url":null,"source":{"id":"https://openalex.org/S7407050956","display_name":"Open Science Framework","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2799848540","host_organization_name":"Center for Open Science","host_organization_lineage":["https://openalex.org/I2799848540"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"StudyRegistration"}],"best_oa_location":{"id":"doi:10.17605/osf.io/8tgx4","doi":"https://doi.org/10.17605/osf.io/8tgx4","is_oa":true,"landing_page_url":"https://doi.org/10.17605/osf.io/8tgx4","pdf_url":null,"source":{"id":"https://openalex.org/S7407050956","display_name":"Open Science Framework","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2799848540","host_organization_name":"Center for Open Science","host_organization_lineage":["https://openalex.org/I2799848540"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"StudyRegistration"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3134839534","https://openalex.org/W7162341151","https://openalex.org/W3124720941","https://openalex.org/W7213744690","https://openalex.org/W2946846371","https://openalex.org/W7213107664","https://openalex.org/W7128627364","https://openalex.org/W7163069860","https://openalex.org/W7154497501","https://openalex.org/W7081150207"],"abstract_inverted_index":{"Personalized":[0,141,625],"mRNA":[1,142,216,234,275,349,354,643,646,675,730,879,1124,1228,1271],"Neoantigen":[2,530],"Vaccines":[3],"in":[4,68,88,111,196,304,950,969,973,1021,1098,1194],"Cancer:":[5],"From":[6],"Tumor":[7,450,469],"Sequencing":[8,453,489],"to":[9,47,128,146,152,180,246,270,288,296,320,337,404,549,562,589,652,661,666,694,865,1006,1036,1131,1162,1215,1243,1248,1273],"Phase":[10,255,406,409,890,998,1039,1044,1048],"3":[11,256,410,891,999,1045,1049],"Clinical":[12,887],"Evidence":[13,888],"Research":[14,262,431],"Project":[15],"Description":[16],"Background":[17],"and":[18,49,65,118,154,211,225,238,254,281,287,324,359,372,389,392,408,417,452,471,486,497,499,515,523,532,555,586,599,611,663,736,777,785,803,860,889,923,1023,1101,1109,1119,1145,1186,1196,1203,1223,1257],"Rationale":[19],"Cancer":[20],"immunotherapy":[21],"has":[22,398,960,994],"transformed":[23],"the":[24,60,66,76,148,181,209,220,247,261,513,521,557,566,597,606,612,654,667,674,691,706,716,729,739,908,955,962,965,1009,1059,1102,1116,1221,1239,1254,1267],"treatment":[25,1168],"of":[26,63,184,214,260,266,517,525,601,608,614,635,673,720,805,817,877,896,904,954,964,1011,1030,1104,1122,1220,1226,1238,1253,1266,1269,1281],"several":[27,696],"advanced":[28,1099],"malignancies,":[29],"particularly":[30,884],"through":[31,228,715,751,844],"immune":[32,77,150,236,369,379,541,668,692,713,826,858,927,943,1106],"checkpoint":[33,370,827,882,944,1140],"inhibitors":[34],"that":[35,71,441,503,708,916,939],"restore":[36],"or":[37,95,170,303,467,718,743,833,1053],"enhance":[38],"antitumor":[39,787],"T-cell":[40,361,622,769,780,796,800,1276],"activity.":[41],"However,":[42],"many":[43],"tumors":[44,64,838],"remain":[45,1051],"resistant":[46],"immunotherapy,":[48],"responses":[50,380,928],"can":[51,72,427,473,575,637,682,711,747,772,783,831,852,924],"vary":[52],"substantially":[53],"between":[54],"patients.":[55],"One":[56,953],"major":[57,671,752,1150],"reason":[58],"is":[59,269,318,677,731,822,920,1153,1159,1213],"biological":[61,1258],"heterogeneity":[62],"differences":[67],"tumor-specific":[69,81,160,357,757,835,931,1275],"antigens":[70,746],"be":[73,244,421,474,563,638,683,749,900,1035,1129],"recognized":[74],"by":[75,85,565,734,856],"system.":[78,669],"Neoantigens":[79],"are":[80,93,166,177,278,334,345,553,560,631,1055],"protein":[82],"sequences":[83],"generated":[84],"somatic":[86,491],"mutations":[87,323,333,544,699],"cancer":[89,108,156,285,374,709,1025],"cells.":[90,759,807],"Because":[91,1156],"they":[92,552],"absent,":[94,97],"largely":[96],"from":[98,136,222,251,400,1042,1245],"normal":[99,465],"tissues,":[100],"neoantigens":[101,134,344,527,618,630,681],"represent":[102],"attractive":[103],"targets":[104,636],"for":[105,168,765,875],"highly":[106,192],"specific":[107],"immunotherapy.":[109],"Advances":[110],"next-generation":[112,477],"sequencing,":[113,483,485,1176],"computational":[114,231,329,547,1177,1256],"biology,":[115],"artificial":[116],"intelligence,":[117],"messenger":[119],"RNA":[120,472],"(mRNA)":[121],"vaccine":[122,202,232,350,820,968,1015,1158,1181,1250],"technology":[123],"have":[124,914,936],"made":[125],"it":[126],"possible":[127],"develop":[129],"individualized":[130,193,348,642,1123],"vaccines":[131,144,176,277,355,880,1272],"containing":[132],"multiple":[133,680,930],"selected":[135,343,655,951],"a":[137,191,437,633,686,721,901,1012,1017,1170,1217],"patient's":[138,149,187,567,1165],"own":[139],"tumor.":[140,188],"neoantigen":[143,175,217,229,276,425,819,918,1014,1229,1262],"aim":[145],"train":[147],"system":[151,693],"recognize":[153],"eliminate":[155],"cells":[157,648,660,710,735,843,864],"carrying":[158],"these":[159,602,841],"mutations.":[161],"Unlike":[162],"conventional":[163],"vaccines,":[164,218],"which":[165,197,332,617,771,782],"designed":[167,1005,1160],"pathogens":[169],"shared":[171],"tumor":[172,198,223,316,444,459,518,536,698,775,806,1166,1174,1246],"antigens,":[173],"personalized":[174,215,274,365,424,878,917,966,1013,1205,1227,1249,1270],"manufactured":[178],"according":[179,1161],"molecular":[182,443,1240],"characteristics":[183],"an":[185,539,641,1163],"individual":[186,1164],"This":[189,204,701],"creates":[190],"therapeutic":[194],"approach":[195,703],"sequencing":[199,227,317,478,519,1195,1247],"directly":[200,773],"informs":[201],"design.":[203],"research":[205,439,898,1112],"project":[206,268,310,434,509,594,761,870,1032,1060,1189,1212],"will":[207,243,311,435,510,595,619,762,871,899,1033,1061,1077,1113,1128,1190],"examine":[208,511,872],"development":[210,257,821,909,1225],"clinical":[212,239,248,284,298,384,402,418,447,873,905,912,948,958,990,1073,1224],"translation":[213],"following":[219],"process":[221,455,662,1202],"sampling":[224],"genomic":[226,501],"identification,":[230],"design,":[233,1182],"manufacturing,":[235,416,1183],"activation,":[237],"evaluation.":[240],"Particular":[241,1126],"attention":[242,1127],"given":[245],"evidence":[249,292,397,764,874,906,938,977,1041],"emerging":[250],"randomized":[252,405,934,976,1003],"trials":[253,1004,1050],"programs.":[258],"Purpose":[259],"The":[263,309,433,454,508,593,645,760,869,992,1075,1111,1188,1211,1231],"primary":[264],"purpose":[265],"this":[267,897,1031,1064,1201],"critically":[271],"evaluate":[272,596,1115],"how":[273,512,1192],"designed,":[279],"developed,":[280],"translated":[282,737],"into":[283,347,382,640,738,997],"treatment,":[286],"determine":[289,550,1007],"whether":[290,551,556,1008],"available":[291],"supports":[293],"their":[294],"potential":[295,325],"improve":[297,947],"outcomes":[299,949,981,1233],"when":[300],"used":[301,319,1242],"alone":[302],"combination":[305,823,970],"with":[306,368,446,457,649,825,881,942,971,983,1139],"standard":[307],"immunotherapies.":[308],"specifically":[312],"investigate:":[313],"1.":[314,449],"How":[315,328,342,353,364,396],"identify":[321,1063],"patient-specific":[322],"neoantigens.":[326,340,592],"2.":[327,529],"algorithms":[330],"predict":[331],"most":[335,956],"likely":[336,561],"generate":[338,620,832,925,1274],"immunogenic":[339],"3.":[341,624],"incorporated":[346,639],"constructs.":[351],"4.":[352,724],"stimulate":[356],"CD4+":[358,778],"CD8+":[360,767],"responses.":[362,623,1107,1277],"5.":[363,808],"vaccination":[366,426,830,855,919,940,1206],"interacts":[367],"blockade":[371,851,945],"other":[373,500,587,1024],"therapies.":[375,886],"6.":[376],"Whether":[377],"vaccine-induced":[378,862,1105],"translate":[381],"measurable":[383,926],"benefits,":[385],"including":[386,493,605,1001],"reduced":[387],"recurrence":[388],"improved":[390,979],"progression-free":[391,1089],"overall":[393,1091],"survival.":[394],"7.":[395],"progressed":[399],"early-phase":[401],"studies":[403,913,935],"2":[407,1040],"trials.":[411],"8.":[412],"What":[413],"technical,":[414],"biological,":[415],"challenges":[419],"must":[420],"addressed":[422],"before":[423],"become":[428],"broadly":[429],"available.":[430],"Approach":[432],"use":[436],"translational":[438,1151],"framework":[440],"connects":[442],"profiling":[445],"outcomes.":[448,1026],"Collection":[451],"begins":[456],"obtaining":[458],"tissue":[460,466],"and,":[461],"where":[462,1093],"appropriate,":[463],"matched":[464],"blood.":[468],"DNA":[470],"analyzed":[475],"using":[476],"approaches":[479],"such":[480,847,1080],"as":[481,848,1071,1081],"whole-exome":[482],"whole-genome":[484],"transcriptomic":[487],"profiling.":[488],"identifies":[490],"alterations,":[492],"single-nucleotide":[494],"variants,":[495],"insertions":[496],"deletions,":[498],"changes":[502],"may":[504,704,791,839,946],"produce":[505,653,1216],"abnormal":[506],"peptides.":[507,744],"quality":[514,1184],"depth":[516],"influence":[520],"number":[522],"reliability":[524],"candidate":[526,591,629],"identified.":[528],"Identification":[531,1252],"Prediction":[533],"Not":[534],"every":[535],"mutation":[537,577],"produces":[538,1016],"effective":[540],"target.":[542],"Candidate":[543],"therefore":[545,853,1034],"undergo":[546],"analysis":[548,1076],"expressed":[554],"resulting":[558],"peptides":[559],"presented":[564,750],"human":[568],"leukocyte":[569],"antigen":[570,1179],"(HLA)":[571],"molecules.":[572],"Bioinformatic":[573],"pipelines":[574],"integrate":[576],"calls,":[578],"gene-expression":[579],"data,":[580],"HLA":[581],"typing,":[582],"peptide-HLA":[583],"binding":[584],"predictions,":[585],"features":[588],"rank":[590],"strengths":[598],"limitations":[600],"prediction":[603],"approaches,":[604],"possibility":[607],"false-positive":[609],"predictions":[610],"difficulty":[613],"accurately":[615],"predicting":[616],"functional":[621],"Vaccine":[626],"Design":[627],"After":[628],"prioritized,":[632],"set":[634],"vaccine.":[644],"provides":[647],"temporary":[650],"instructions":[651],"antigenic":[656,741],"sequences,":[657],"allowing":[658,690,861],"antigen-presenting":[659],"present":[664],"them":[665],"A":[670,893,1027,1149,1235,1278],"advantage":[672],"platform":[676],"its":[678],"flexibility:":[679],"encoded":[684,740],"within":[685],"single":[687,722],"vaccine,":[688],"potentially":[689],"target":[695],"independent":[697],"simultaneously.":[700],"multi-target":[702],"reduce":[705],"likelihood":[707],"escape":[712],"recognition":[714,804],"loss":[717],"alteration":[719],"antigen.":[723],"Immune":[725,789,811],"Activation":[726],"Following":[727],"vaccination,":[728],"taken":[732],"up":[733],"proteins":[742],"These":[745],"subsequently":[748,995],"histocompatibility":[753],"complex":[754],"pathways,":[755],"activating":[756],"T":[758,836,842,863],"assess":[763],"both":[766],"cytotoxic":[768],"responses,":[770,781,802],"kill":[774],"cells,":[776,837],"helper":[779],"support":[784],"sustain":[786],"immunity.":[788],"monitoring":[790],"include":[792],"assays":[793],"measuring":[794],"neoantigen-specific":[795],"expansion,":[797],"cytokine":[798],"production,":[799],"receptor":[801],"Combination":[809],"With":[810],"Checkpoint":[812,850],"Inhibitors":[813],"An":[814,1264],"important":[815,957],"component":[816,895],"current":[818],"therapy":[824],"inhibitors.":[828],"Although":[829],"expand":[834],"suppress":[840],"inhibitory":[845],"pathways":[846],"PD-1/PD-L1.":[849],"complement":[854],"reducing":[857],"suppression":[859],"function":[866],"more":[867,1207],"effectively.":[868],"combinations":[876],"inhibitors,":[883],"anti-PD-1":[885],"Translation":[892],"central":[894],"critical":[902,1279],"assessment":[903,1219],"across":[907],"pathway.":[910],"Early":[911],"demonstrated":[915],"technically":[921],"feasible":[922],"against":[929],"targets.":[932],"Subsequent":[933],"provided":[937],"combined":[941],"cancers.":[952],"developments":[959],"been":[961],"evaluation":[963,1265],"mRNA-4157/V940":[967],"pembrolizumab":[972,984],"melanoma.":[974],"Earlier":[975],"reported":[978],"recurrence-related":[980],"compared":[982],"alone,":[985],"supporting":[986],"progression":[987],"toward":[988],"late-stage":[989],"development.":[991],"field":[993],"moved":[996],"evaluation,":[1000],"large":[1002],"addition":[1010],"clinically":[1018],"meaningful":[1019],"improvement":[1020],"recurrence-free":[1022,1082],"key":[1028],"objective":[1029,1095],"distinguish":[1037],"promising":[1038],"definitive":[1043],"evidence.":[1046],"Where":[1047],"ongoing":[1052],"results":[1054],"not":[1056],"yet":[1057],"mature,":[1058],"explicitly":[1062],"limitation":[1065],"rather":[1066],"than":[1067],"treating":[1068],"investigational":[1069],"findings":[1070],"established":[1072],"benefit.":[1074],"compare":[1078],"endpoints":[1079],"survival,":[1083,1086,1088,1090],"distant":[1084],"metastasis-free":[1085],"event-free":[1087],"survival":[1092],"available,":[1094],"response":[1096],"rates":[1097],"disease,":[1100],"durability":[1103],"Safety":[1108],"Feasibility":[1110],"also":[1114],"safety":[1117],"profile":[1118],"practical":[1120],"feasibility":[1121],"vaccination.":[1125],"paid":[1130],"treatment-related":[1132],"adverse":[1133,1136,1147],"events,":[1134],"immune-related":[1135],"events":[1137],"associated":[1138],"inhibition,":[1141],"vaccine-associated":[1142],"systemic":[1143],"reactions,":[1144],"serious":[1146],"events.":[1148],"challenge":[1152],"manufacturing":[1154,1197],"speed.":[1155],"each":[1157],"mutations,":[1167],"requires":[1169],"coordinated":[1171],"workflow":[1172],"involving":[1173],"sampling,":[1175],"analysis,":[1178],"selection,":[1180],"control,":[1185],"administration.":[1187],"investigate":[1191],"improvements":[1193],"technologies":[1198],"could":[1199],"shorten":[1200],"make":[1204],"scalable.":[1208],"Expected":[1209],"Outcomes":[1210],"expected":[1214],"comprehensive":[1218],"scientific":[1222],"vaccines.":[1230],"anticipated":[1232],"include:":[1234],"detailed":[1236],"description":[1237],"pipeline":[1241],"move":[1244],"production.":[1251],"principal":[1255],"factors":[1259],"determining":[1260],"successful":[1261],"selection.":[1263],"ability":[1268],"synthesis":[1280],"clinic":[1282]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-09-03T00:00:00"}